First Japanese Patients Randomized In Corvia Medical’s REDUCE LAP-HF II Global Clinical Trial For Heart Failure
- Monday, January 13, 2020, 7:14
- PR Newswire
- Add a comment
TEWKSBURY, Mass., Jan. 13, 2020 /PRNewswire/ — Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced the first Japanese patients were randomized in Toyama and Hyogo under a clinical trial authorization from…
About the Author
admin has written 21810 stories on this site.